COPD Clinical Trials in Chicago

Showing 41-60 of 142 trials

Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary

NCT01397721

The Multi-Ethnic Study of Atherosclerosis (MESA) - Chronic Obstructive Pulmonary Disease (COPD) Study aims to characterize the pulmonary vascular changes and their biology in early COPD using imaging, gene expression profiling and peripheral cellular measures.

Chronic Obstructive Pulmonary Disease

Columbia University359 participantsStarted May 2009

Alhambra, California, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +1 more locations

COMPLETEDPhase 32.2 miles

Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)

NCT03137303

The purpose of this study is to evaluate the use of spirometry in identifying Diagnostic Error in COPD and Asthma patients.

COPD Asthma

University of Illinois at Chicago402 participantsStarted Jul 2017

Chicago, Illinois, United States • Chicago, Illinois, United States

TERMINATEDPhase 32.2 miles

A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)

NCT03496623

The primary objective of this study is to demonstrate the efficacy of inhaled treprostinil compared to placebo in improving exercise ability as measured by change from baseline in 6-Minute Walk Distance (6MWD) following 12 weeks of active treatment in participants with PH-COPD.

Pulmonary HypertensionChronic Obstructive Pulmonary Disease

United Therapeutics188 participantsStarted May 2018

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +73 more locations

PreviousPage 3 of 8Next

Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary

Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)

A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)

COPD Trials in Other Cities

Feasibility of At-Home Handheld Spirometry

Respiratory Infection Monitoring

Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD

At Home Spirometry and Video Module Education for COPD Patients

A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease

A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD

Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Home Pulmonary Rehabilitation for COPD

Improving Quality by Maintaining Accurate Problems in the EHR

An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 2)

Exacerbations and Their Outcomes International (EXACOS International)

Evaluation of VQm PHM on Pulmonary Health Parameters for ICU

Other Conditions in Chicago